Literature DB >> 25220160

Optimal structural design of mannosylated nanocarriers for macrophage targeting.

Peiming Chen1, Xiaoping Zhang2, Lee Jia3, Robert K Prud'homme4, Zoltan Szekely5, Patrick J Sinko6.   

Abstract

Macrophages are involved in a number of diseases, such as HIV infection/AIDS, tuberculosis, tumor development and atherosclerosis. Macrophages possess several cell surface receptors (e.g., the mannose receptor, MR) that may serve as drug delivery cellular portals for nanocarriers (NCs). In this study, the optimal structural configuration for cell uptake of mannosylated poly(ethylene glycol)-conjugate type NCs was determined. A series of NCs were synthesized to systematically evaluate the effects of the number of mannose units (Man), the PEG carrier size and the mPEG spacer length between adjacent mannose units on NC uptake into MR-expressing J774.E murine macrophage-like cells. Among NCs with 0, 1, 2 or 4 units of mannose, the uptake of (Man)2-NC was the highest, suggesting a trade-off between avidity and NC-MR clustering on the cell surface that sterically hinders endocytosis. This optimal (Man)2-NC configuration was built into subsequent NCs to optimize the other two parameters, PEG carrier size and spacer length. NCs with 0, 5, 12, 20, 30 or 40 kDa linear PEG carriers showed an inverse relationship between PEG size and uptake. The 12 kDa PEG carrier was chosen for investigating the third parameter, the Man-Man distance, since it may represent the best trade off (i.e., tissue penetration vs. systemic clearance) for in vivo macrophage targeting. Three (Man)2-PEG12kDa NCs with different Man-Man distances (39, 56 or 89Å) were synthesized. The uptake of the NC with the 56Å distance between mannoses was four- and two-fold higher than NCs with 39Å and 89Å distances, respectively. Confocal microscopy confirmed that the optimized (Man)2-PEG12kDa NC with the 56Å Man-Man distance was internalized via endocytosis consistent with temperature-dependent active uptake. In conclusion, the optimal NC structural parameters for targeting the MR on macrophage-like J774.E cells are (i) a small PEG polymer carrier, (ii) two mannose units per NC and (iii) a 56Å distance between adjacent mannose units.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; HIV-1; Ligand design; Mannose receptor; Nanocarrier

Mesh:

Substances:

Year:  2014        PMID: 25220160      PMCID: PMC4254139          DOI: 10.1016/j.jconrel.2014.09.006

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  61 in total

Review 1.  Fcgamma receptor 1 (CD64), a target beyond cancer.

Authors:  T Thepen; M Huhn; G Melmer; M K Tur; S Barth
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 2.  Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.

Authors:  Ruth Duncan; Simon C W Richardson
Journal:  Mol Pharm       Date:  2012-08-20       Impact factor: 4.939

3.  Protein concentration in interstitial and lymphatic fluids from the subcutaneous tissue.

Authors:  G Rutili; K E Arfors
Journal:  Acta Physiol Scand       Date:  1977-01

4.  Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities.

Authors:  Reiko T Lee; Tsui-Ling Hsu; Shau Ku Huang; Shie-Liang Hsieh; Chi-Huey Wong; Yuan C Lee
Journal:  Glycobiology       Date:  2010-11-26       Impact factor: 4.313

Review 5.  Binding and cross-linking properties of galectins.

Authors:  C Fred Brewer
Journal:  Biochim Biophys Acta       Date:  2002-09-19

Review 6.  C-type lectins and phagocytosis.

Authors:  Ann M Kerrigan; Gordon D Brown
Journal:  Immunobiology       Date:  2009-03-03       Impact factor: 3.144

7.  Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

Authors:  Huanyu Dou; Cassi B Grotepas; JoEllyn M McMillan; Christopher J Destache; Mahesh Chaubal; Jane Werling; James Kipp; Barrett Rabinow; Howard E Gendelman
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

Review 8.  Mannose-targeted systems for the delivery of therapeutics.

Authors:  Juan M Irache; Hesham H Salman; Carlos Gamazo; Socorro Espuelas
Journal:  Expert Opin Drug Deliv       Date:  2008-06       Impact factor: 6.648

Review 9.  Multivalent glycocalixarenes for recognition of biological macromolecules: glycocalyx mimics capable of multitasking.

Authors:  Francesco Sansone; Alessandro Casnati
Journal:  Chem Soc Rev       Date:  2013-01-29       Impact factor: 54.564

10.  A review on composite liposomal technologies for specialized drug delivery.

Authors:  Maluta S Mufamadi; Viness Pillay; Yahya E Choonara; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo
Journal:  J Drug Deliv       Date:  2011-02-08
View more
  7 in total

1.  Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: formulation development and in vitro and in vivo evaluation.

Authors:  Keerti Jain; Ashwni Kumar Verma; Prabhat Ranjan Mishra; Narendra Kumar Jain
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 2.  Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.

Authors:  Erika Dosekova; Jaroslav Filip; Tomas Bertok; Peter Both; Peter Kasak; Jan Tkac
Journal:  Med Res Rev       Date:  2016-11-15       Impact factor: 12.944

3.  Advances in nanomedicine drug delivery applications for HIV therapy.

Authors:  Paul Curley; Neill J Liptrott; Andrew Owen
Journal:  Future Sci OA       Date:  2017-09-06

4.  Targeting Beclin1 as an Adjunctive Therapy against HIV Using Mannosylated Polyethylenimine Nanoparticles.

Authors:  Myosotys Rodriguez; Yemmy Soler; Mohan Kumar Muthu Karuppan; Yuling Zhao; Elena V Batrakova; Nazira El-Hage
Journal:  Pharmaceutics       Date:  2021-02-06       Impact factor: 6.321

5.  Computer simulation of the Receptor-Ligand Interactions of Mannose Receptor CD206 in Comparison with the Lectin Concanavalin A Model.

Authors:  Igor D Zlotnikov; Elena V Kudryashova
Journal:  Biochemistry (Mosc)       Date:  2022-01       Impact factor: 2.824

Review 6.  Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.

Authors:  Antoinette G Nelson; Xiaoping Zhang; Usha Ganapathi; Zoltan Szekely; Charles W Flexner; Andrew Owen; Patrick J Sinko
Journal:  J Control Release       Date:  2015-08-24       Impact factor: 9.776

Review 7.  Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting.

Authors:  Maria Luisa Fiani; Valeria Barreca; Massimo Sargiacomo; Flavia Ferrantelli; Francesco Manfredi; Maurizio Federico
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.